Synthesis and biological evaluation of a series of aromatic bisphosphonates
摘要:
Geminal bisphosphonates display varied biological activity depending on the nature of the substituents on the central carbon atom. For example, the nitrogenous bisphosphonates zoledronate and risedronate inhibit the enzyme farnesyl diphosphate synthase while digeranyl bisphosphonate has been shown to inhibit the enzyme geranylgeranyl diphosphate synthase. We now have synthesized isoprenoid bisphosphonates where an aromatic ring has been used to replace one of the isoprenoid olefins in an isoprenoid bisphosphonate and investigated the ability of these new compounds to impair protein geranylgeranylation within cells. Several of these new compounds are potent inhibitors of the enzyme geranylgeranyl diphosphate synthase. (C) 2010 Elsevier Ltd. All rights reserved.
Prenylated Bisphosphonates as Anti-tuberculosis Agents
申请人:Wiemer David F.
公开号:US20100240612A1
公开(公告)日:2010-09-23
The invention provides methods to treat a mycobacterium infection and methods to inhibit mycobacterial polyprenyl pyrophosphate synthesis with a compound of formula I. The invention also provides novel compounds of formula I as well as salts and prodrugs thereof.
PRENYLATED BISPHOSPHONATES AS ANTI-TUBERCULOSIS AGENTS
申请人:University of Iowa Research Foundation
公开号:EP2408447A1
公开(公告)日:2012-01-25
[EN] PRENYLATED BISPHOSPHONATES AS ANTI-TUBERCULOSIS AGENTS<br/>[FR] BISPHOSPHONATES PRÉNYLÉS EN TANT QU'AGENTS ANTITUBERCULEUX
申请人:UNIV IOWA RES FOUND
公开号:WO2010108190A1
公开(公告)日:2010-09-23
The invention provides methods to treat a mycobacterium infection and methods to inhibit mycobacterial polyprenyl pyrophosphate synthesis with a compound of formula I. The invention also provides novel compounds of formula I as well as salts and prodrugs thereof.
Synthesis and biological evaluation of a series of aromatic bisphosphonates
作者:Rocky J. Barney、Brian M. Wasko、Amel Dudakovic、Raymond J. Hohl、David F. Wiemer
DOI:10.1016/j.bmc.2010.08.036
日期:2010.10.15
Geminal bisphosphonates display varied biological activity depending on the nature of the substituents on the central carbon atom. For example, the nitrogenous bisphosphonates zoledronate and risedronate inhibit the enzyme farnesyl diphosphate synthase while digeranyl bisphosphonate has been shown to inhibit the enzyme geranylgeranyl diphosphate synthase. We now have synthesized isoprenoid bisphosphonates where an aromatic ring has been used to replace one of the isoprenoid olefins in an isoprenoid bisphosphonate and investigated the ability of these new compounds to impair protein geranylgeranylation within cells. Several of these new compounds are potent inhibitors of the enzyme geranylgeranyl diphosphate synthase. (C) 2010 Elsevier Ltd. All rights reserved.